Síndrome de hiperestimulación ovárica

@inproceedings{Arreola2010SndromeDH,
  title={S{\'i}ndrome de hiperestimulaci{\'o}n ov{\'a}rica},
  author={Ranferi Gaona Arreola and Eliana Cejudo Carranza and Laura Hern{\'a}ndez Gurrola},
  year={2010}
}
Drugs prescribed to induce ovulation in women with difficulties to achieve a pregnancy provoke potentially severe complications and may cause ovarian hyperstimulation syndrome, which is characterized by an increased ovarian volume, extravascular volume accumulation and reduced intravascular volume, electrolytic disorders, renal failure and tromboembolic disorders, which may put patient’s life at risk. This paper includes epidemiology, classification, risk factors, treatment, prevention and… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 30 REFERENCES

Clinical aspects of ovarian hyperstimulation syndrome.

  • European journal of obstetrics, gynecology, and reproductive biology
  • 1999

Elevated levels of interleukin in patients with ovarian hyperstimulation syndrome

M. Aboulghar
  • Eur J Obstet Gynecol Reprod Biol
  • 1999